NO20076683L - Cyanopyrrol-sulfonamid progesteron reseptormodulatorer og deres anvendelse - Google Patents

Cyanopyrrol-sulfonamid progesteron reseptormodulatorer og deres anvendelse

Info

Publication number
NO20076683L
NO20076683L NO20076683A NO20076683A NO20076683L NO 20076683 L NO20076683 L NO 20076683L NO 20076683 A NO20076683 A NO 20076683A NO 20076683 A NO20076683 A NO 20076683A NO 20076683 L NO20076683 L NO 20076683L
Authority
NO
Norway
Prior art keywords
receptor modulators
progesterone receptor
cyanopyrrole
sulfonamide
contraception
Prior art date
Application number
NO20076683A
Other languages
English (en)
Inventor
Andrew Fensome
Casey Cameron Mccomas
Edward George Melenski
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20076683L publication Critical patent/NO20076683L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Det beskrives progesteronreseptor-modulatorer med formel I, eller et farmasøytisk akseptabelt salt derav, I hvor R1, R2, R3, R4, R5, R6 og R7 er som definert her, som er anvendelige for prevensjon og hormonerstatningsterapi. Det tilveiebringes også produkter inneholdende disse forbindelser.
NO20076683A 2005-07-29 2007-12-28 Cyanopyrrol-sulfonamid progesteron reseptormodulatorer og deres anvendelse NO20076683L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70400905P 2005-07-29 2005-07-29
PCT/US2006/029125 WO2007016212A1 (en) 2005-07-29 2006-07-27 Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof

Publications (1)

Publication Number Publication Date
NO20076683L true NO20076683L (no) 2008-02-04

Family

ID=37309001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076683A NO20076683L (no) 2005-07-29 2007-12-28 Cyanopyrrol-sulfonamid progesteron reseptormodulatorer og deres anvendelse

Country Status (22)

Country Link
US (1) US7291643B2 (no)
EP (1) EP1910285A1 (no)
JP (1) JP5185114B2 (no)
KR (1) KR20080031915A (no)
CN (1) CN101233104A (no)
AR (1) AR056005A1 (no)
AU (1) AU2006275833B2 (no)
BR (1) BRPI0614412A2 (no)
CA (1) CA2612977A1 (no)
CR (1) CR9627A (no)
EC (1) ECSP088147A (no)
GT (1) GT200600336A (no)
HN (1) HN2008000135A (no)
IL (1) IL188314A (no)
MX (1) MX2008001338A (no)
NO (1) NO20076683L (no)
PE (1) PE20070404A1 (no)
RU (1) RU2007148077A (no)
SA (1) SA06270246B1 (no)
TW (1) TW200734302A (no)
UA (1) UA92500C2 (no)
WO (1) WO2007016212A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
PE20070182A1 (es) * 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
TW200848021A (en) * 2007-03-06 2008-12-16 Wyeth Corp Sulfonylated heterocycles useful for modulation of the progesterone receptor
TW200848019A (en) * 2007-03-06 2008-12-16 Wyeth Corp Aryl sulfonamides useful for modulation of the progesterone receptor
EA201070715A1 (ru) * 2007-12-20 2011-02-28 Тева Вимен'С Хелс, Инк. Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции
KR20150105302A (ko) 2012-11-05 2015-09-16 난트 홀딩스 아이피, 엘엘씨 헤지 호그 신호 경로의 억제제로서 환상 술폰아미드 함유 유도체

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680413A (en) 1986-01-17 1987-07-14 Nippon Soda Co., Ltd. Process for the production of 3-phenyl-4-cyanopyrroles
US5455263A (en) 1987-07-29 1995-10-03 American Cyanamid Company Methods for the control and the protection of warm-blooded animals against infestation and infection by helminths, acarids and arthropod endo- and ectoparasites
EP0339342A1 (de) 1988-04-23 1989-11-02 Bayer Ag N-Substituierte N-Amino-pyrrole
GB8903592D0 (en) 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents
DE4036645A1 (de) 1990-11-16 1992-05-21 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung
JP2699024B2 (ja) 1990-11-22 1998-01-19 富士写真フイルム株式会社 新規な色素形成カプラーおよび該カプラーを含有するハロゲン化銀カラー写真感光材料
US5236925A (en) 1991-10-24 1993-08-17 American Home Products Corporation Fused pyrimidines as angiotensin II antagonists
US5187168A (en) 1991-10-24 1993-02-16 American Home Products Corporation Substituted quinazolines as angiotensin II antagonists
WO1994017059A1 (fr) 1993-01-29 1994-08-04 Nippon Soda Co., Ltd. Derive heterocyclique
EP0842923B1 (en) 1995-06-07 2006-03-01 Nippon Shinyaku Company, Limited Pyrrole derivatives and medicinal composition
US6013421A (en) 1996-07-19 2000-01-11 Fuji Photo Film Co., Ltd. Silver halide photographic light-sensitive material and image-forming method
US20010007867A1 (en) 1999-12-13 2001-07-12 Yuhpyng L. Chen Substituted 6,5-hetero-bicyclic derivatives
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
EP1370557B1 (en) 2001-03-09 2005-11-16 Pfizer Products Inc. Benzimidazole anti-inflammatory compounds
IL156567A0 (en) 2001-03-09 2004-01-04 Pfizer Prod Inc Triazolopyridines as anti-inflammatory agents
EP1247810B1 (en) 2001-04-04 2005-09-07 Pfizer Products Inc. Novel benzotriazoles anti-inflammatory compounds
CA2505361A1 (en) 2002-11-11 2004-05-27 Bayer Healthcare Ag Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
CA2515440A1 (fr) 2003-02-12 2004-09-02 L'oreal Utilisation d'un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres
CN1946716B (zh) * 2004-04-27 2011-12-21 惠氏公司 含有氰基吡咯的环状氨基甲酸酯和硫代氨基甲酸酯联芳基以及其制备方法
GT200500183A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
GT200500185A (es) 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos

Also Published As

Publication number Publication date
US20070027126A1 (en) 2007-02-01
US7291643B2 (en) 2007-11-06
IL188314A (en) 2012-09-24
GT200600336A (es) 2007-05-28
MX2008001338A (es) 2008-03-25
KR20080031915A (ko) 2008-04-11
TW200734302A (en) 2007-09-16
EP1910285A1 (en) 2008-04-16
BRPI0614412A2 (pt) 2016-11-22
WO2007016212A1 (en) 2007-02-08
CR9627A (es) 2008-03-06
AR056005A1 (es) 2007-09-12
UA92500C2 (ru) 2010-11-10
JP2009502947A (ja) 2009-01-29
IL188314A0 (en) 2008-04-13
JP5185114B2 (ja) 2013-04-17
CA2612977A1 (en) 2007-02-08
CN101233104A (zh) 2008-07-30
PE20070404A1 (es) 2007-05-10
SA06270246B1 (ar) 2010-11-22
ECSP088147A (es) 2008-02-20
AU2006275833A1 (en) 2007-02-08
HN2008000135A (es) 2010-08-19
AU2006275833B2 (en) 2012-04-26
RU2007148077A (ru) 2009-09-10

Similar Documents

Publication Publication Date Title
NO20082445L (no) Neuropeptid-2 reseptor-agonister
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
NO20076134L (no) Benzamidderivater og anvendelser derav
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20091409L (no) Pyridin-3-yl-derivater som immunmodulerende midler
NO20055135L (no) Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer
NO20084307L (no) Heterocykliske GPCR agonister
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
NO20073664L (no) Peptider med neuropeptid-2-reseptor (Y2R) agonist aktivitet
NO20091394L (no) Pyridin-4-yl-derivater som immunmodulerende midler
NO20090628L (no) Pyridizinon derivativater
UA94600C2 (en) Indole sulfonamide modulators of progesterone receptors
DK1833799T3 (da) 3-phenyl-pyrazol derivater, som modulatorer af 5-HT-2a-serotonin receptor nyttig til behandlingen af sygdomme relateret hertil
NO20054905L (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
DK1697371T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
CR9078A (es) Derivado de bencimidazol ariloxi-sustituidos
NO20065878L (no) Terapeutiske forbindelser
MX2010006230A (es) Derivados de arilamida substituidos con triazol y su uso como antagonistas de receptor purinergico p2x3 y/o p2x2/3.
MX2011006843A (es) Dihidropiridona-amidas como moduladores de p2x7.
NO20070723L (no) Progesteron reseptormodulatorer inneholdende pyrrol-oksindolderivater og deres anvendelse
NO20080394L (no) N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav
NO20083058L (no) Cykloheksylsulfonamidderivater med H3 reseptor aktivitet
NO20065904L (no) Terapeutiske forbindelser
NO20070570L (no) Forbindelser.
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application